Abstract
Acute respiratory failure (ARF) requiring mechanical ventilation, a complicating factor in sepsis and other disorders, is associated with high morbidity and mortality. Despite its severity and prevalence, treatment options are limited. In light of accumulating evidence that mitochondrial abnormalities are common in ARF, here we applied broad spectrum quantitative and semiquantitative metabolomic analyses of serum from ARF patients to detect bioenergetic dysfunction and determine its association with survival. Plasma samples from surviving and non-surviving patients (N = 15/group) were taken at day 1 and day 3 after admission to the medical intensive care unit and, in survivors, at hospital discharge. Significant differences between survivors and non-survivors (ANOVA, 5% FDR) include bioenergetically relevant intermediates of redox cofactors nicotinamide adenine dinucleotide (NAD) and NAD phosphate (NADP), increased acyl-carnitines, bile acids, and decreased acyl-glycerophosphocholines. Many metabolites associated with poor outcomes are substrates of NAD(P)-dependent enzymatic processes, while alterations in NAD cofactors rely on bioavailability of dietary B-vitamins thiamine, riboflavin and pyridoxine. Changes in the efficiency of the nicotinamide-derived cofactors' biosynthetic pathways also associate with alterations in glutathione-dependent drug metabolism characterized by substantial differences observed in the acetaminophen metabolome. Based on these findings, a four-feature model developed with semi-quantitative and quantitative metabolomic results predicted patient outcomes with high accuracy (AUROC = 0.91). Collectively, this metabolomic endotype points to a close association between mitochondrial and bioenergetic dysfunction and mortality in human ARF, thus pointing to new pharmacologic targets to reduce mortality in this condition.
Document Type
Article
Publication Date
5-18-2021
Digital Object Identifier (DOI)
https://doi.org/10.1038/s41598-021-89716-0
Funding Information
NR011186; Dr. Langley is partially funded by NIH (KL2TR003097 and UL1 TR001417). Dr. Migaud is partially funded by Elysium Health and NIH (NCCIH R21 Grant AT009908). Dr. Gillespie is partially supported by NIH (R01 HL113614, R01 GM127823, and UL1 TR001417).
Repository Citation
Langley, Raymond J.; Migaud, Marie E.; Flores, Lori; Thompson, J. Will; Kean, Elizabeth A.; Mostellar, Murphy M.; Mowry, Matthew; Luckett, Patrick; Purcell, Lina D.; Lovato, James; Gandotra, Sheetal; Benton, Ryan; Files, D. Clark; Harrod, Kevin S.; Gillespie, Mark N.; and Morris, Peter E., "A Metabolomic Endotype of Bioenergetic Dysfunction Predicts Mortality in Critically Ill Patients with Acute Respiratory Failure" (2021). Internal Medicine Faculty Publications. 240.
https://uknowledge.uky.edu/internalmedicine_facpub/240
Supplementary information
Notes/Citation Information
Published in Scientific Reports, v. 11, issue 1, article no. 10515.
© The Author(s) 2021
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.